Eli 20 mg Aurochem Pharmaceuticals

£132.00

Eli 20 mg represents pharmaceutical-grade tadalafil citrate formulations designed for laboratory research examining PDE5 inhibition and cardiovascular endothelial function. Available for comprehensive in-vitro investigations.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Eli 20 mg Aurochem Pharmaceuticals
Eli 20 mg Aurochem Pharmaceuticals
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Eli — Research Summary

Eli 20 mg is a pharmaceutical-grade tadalafil citrate preparation manufactured by Aurochem Pharmaceuticals for laboratory research applications. Tadalafil citrate is a selective phosphodiesterase type 5 (PDE5) inhibitor that researchers study to investigate vascular endothelial function, nitric oxide signalling pathways, and cardiovascular research models. This compound enables scientists to examine the molecular mechanisms underlying PDE5 inhibition in controlled laboratory environments. Researchers at Stroid UK Shop utilise this formulation to study cyclic guanosine monophosphate (cGMP) pathway modulation and smooth muscle cell function in various experimental protocols.

Laboratory Applications

Scientific investigations frequently study tadalafil citrate for its role in nitric oxide-cGMP signalling cascade research. Laboratory studies examine how PDE5 inhibition affects intracellular calcium handling in smooth muscle cells and endothelial function markers. Researchers investigate this compound’s effects on pulmonary arterial pressure models and cardiovascular tissue responses in controlled experimental settings. The pharmaceutical preparation allows for precise dosing in research protocols examining vascular reactivity and endothelial-dependent vasodilation mechanisms. Scientists working with erection drugs research compounds frequently incorporate tadalafil citrate studies alongside other PDE inhibitor investigations. Some research laboratories also examine potential applications in pulmonary hypertension models and cardiac tissue studies, while others investigate interactions with SARM compounds or peptide research materials in comprehensive experimental designs.

Specifications

Eli 20 mg Technical Specifications
Parameter Specification
Active Ingredient Tadalafil Citrate
Strength 20 mg per tablet
Manufacturer Aurochem Pharmaceuticals
Form Oral tablet
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Storage Room temperature, dry conditions

Research Compliance

Eli 20 mg tadalafil citrate is supplied exclusively for in-vitro laboratory research and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory conditions and follow institutional research protocols when handling this compound. All studies should be conducted under proper scientific supervision with appropriate safety measures and documentation procedures in accredited research facilities.

Related